BioMarin
Generated by Meeveem AI
"A global leader in rare disease biotechnology transforming lives through genetic discovery"
About BioMarin
BioMarin develops medicines for people living with genetically defined rare diseases. Founded in 1997 and headquartered in San Rafael, California, it has nine commercial therapies and a pipeline of clinical and preclinical candidates. The company operates in approximately 80 countries, using genetic insights to target the underlying changes or molecular mechanisms of disease.
Its work brings together research, clinical development, manufacturing and commercial teams. Manufacturing facilities in Northern California and Ireland produce active pharmaceutical ingredients for certain medicines, alongside external manufacturing partners. BioMarin engages with patient communities and healthcare professionals, and its UK operation includes London-based medical, regulatory and market access work.
Professional growth
BioMarin supports employee development through on-the-job experience and formal learning. Opportunities include face-to-face, virtual and self-directed learning, mentoring and external development. Its responsibility report describes ongoing coaching conversations and quarterly check-ins focused on work and career development.
Connections across the organisation
Employee-led resource groups are open to colleagues around the world and organise events that connect people across the company. The Your Voice survey provides another route for staff feedback and dialogue between managers and teams.
3221
Team Members
1997
Founded
Biotechnology
Sector
Hybrid
Work Environment